We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$87M
2
QSR icon
Restaurant Brands International
QSR
+$63.5M
3
BIP icon
Brookfield Infrastructure Partners
BIP
+$62.1M
4
AZN icon
AstraZeneca
AZN
+$55.4M
5
AQN icon
Algonquin Power & Utilities
AQN
+$54.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$159M
2
RY icon
Royal Bank of Canada
RY
+$100M
3
VRN
Veren
VRN
+$89.9M
4
WPM icon
Wheaton Precious Metals
WPM
+$88.9M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$78.3M

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHL
926
DELISTED
Greenhill & Co., Inc.
GHL
$211K ﹤0.01%
22,853
-13,403
-37% -$164K
KRYS icon
927
Krystal Biotech
KRYS
$9.74B
$210K ﹤0.01%
+3,202
New +$199K
SIBN icon
928
SI-BONE Inc
SIBN
$847M
$210K ﹤0.01%
15,937
+5,559
+54% +$92.6K
RNAC icon
929
Cartesian Therapeutics
RNAC
$267M
$208K ﹤0.01%
5,296
-6,496
-55% -$193K
BPRN icon
930
Princeton Bancorp
BPRN
$295M
$207K ﹤0.01%
7,537
-1,992
-21% -$57.5K
EMR icon
931
Emerson Electric
EMR
$91.2B
$207K ﹤0.01%
+2,600
New +$229K
KPTI icon
932
Karyopharm Therapeutics
KPTI
$45.3M
$207K ﹤0.01%
+3,065
New +$281K
CFMS
933
DELISTED
Conformis, Inc. Common Stock
CFMS
$206K ﹤0.01%
23,297
-1,830
-7% -$20.9K
WB icon
934
Weibo
WB
$1.87B
$204K ﹤0.01%
+8,805
New +$197K
PRDO icon
935
Perdoceo Education
PRDO
$2.01B
$201K ﹤0.01%
+17,035
New +$187K
SLG icon
936
SL Green Realty
SLG
$4.09B
$201K ﹤0.01%
+4,348
New +$277K
HL icon
937
Hecla Mining
HL
$11.9B
$196K ﹤0.01%
+50,027
New +$260K
GTHX
938
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$196K ﹤0.01%
+39,658
New +$220K
QUAD icon
939
Quad
QUAD
$503M
$194K ﹤0.01%
70,539
-91,832
-57% -$444K
DOC
940
DELISTED
PHYSICIANS REALTY TRUST
DOC
$188K ﹤0.01%
+10,793
New +$191K
REPL icon
941
Replimune Group
REPL
$1.42B
$187K ﹤0.01%
+10,718
New +$176K
TKC icon
942
Turkcell
TKC
$4.74B
$186K ﹤0.01%
74,557
+12,294
+20% +$39.8K
MCRB icon
943
Seres Therapeutics
MCRB
$45.8M
$182K ﹤0.01%
2,650
-6,154
-70% -$530K
DRRX
944
DELISTED
DURECT Corp
DRRX
$179K ﹤0.01%
37,425
+29,552
+375% +$141K
CONN
945
DELISTED
Conn's Inc.
CONN
$177K ﹤0.01%
+22,061
New +$290K
GRFS
946
Grifois
GRFS
$5.43B
$173K ﹤0.01%
14,543
-20,548
-59% -$245K
OPBK icon
947
OP Bancorp
OPBK
$234M
$170K ﹤0.01%
16,178
-3,089
-16% -$37.8K
PGEN icon
948
Precigen
PGEN
$2.34B
$170K ﹤0.01%
127,039
+96,454
+315% +$143K
SAN icon
949
Banco Santander
SAN
$211B
$170K ﹤0.01%
60,690
-1,416,356
-96% -$4.33M
AVXL icon
950
Anavex Life Sciences
AVXL
$305M
$169K ﹤0.01%
+16,922
New +$160K
36 37
38
39 40

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.